Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial

(2011) Gunnar M. Buyse et al.   NEUROMUSCULAR DISORDERS

NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels

(2011) Roman H. Haefeli et al.   PLoS One

Pharmacokinetic evaluation of idebenone

(2010) Claudia Becker et al.   Expert Opinion on Drug Metabolism & Toxicology

The respiratory management of patients with duchenne muscular dystrophy: A DMD care considerations working group specialty article

(2010) David J. Birnkrant et al.   PEDIATRIC PULMONOLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

(2008) G. M. Buyse et al.   EUROPEAN HEART JOURNAL

Early Regional Myocardial Dysfunction in Young Patients With Duchenne Muscular Dystrophy

(2008) Luc Mertens et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY